IPSEN SA ADR Current Ratio 2016-2020 | IPSEY

Current and historical current ratio for IPSEN SA ADR (IPSEY) from 2016 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. IPSEN SA ADR current ratio for the three months ending June 30, 2020 was .
IPSEN SA ADR Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $1.55B $1.47B 1.06
2019-12-31 $1.51B $1.63B 0.93
2018-12-31 $1.40B $1.13B 1.24
2017-12-31 $1.15B $1.07B 1.08
2017-06-30 $1.02B $1.01B 1.00
2016-12-31 $1.16B $0.62B 1.87
2016-06-30 $1.09B $0.49B 2.23
2015-12-31 $0.90B $0.51B 1.76
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.040B $3.016B
Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.499B 41.70
Takeda Pharmaceutical (TAK) Japan $56.434B 10.53
Astellas Pharma (ALPMY) Japan $29.621B 18.50
Merck (MKGAF) Germany $23.632B 0.00
Eisai (ESALY) Japan $21.928B 19.11
UCB SA (UCBJF) Belgium $20.583B 0.00
Catalent (CTLT) United States $18.980B 56.77
Grifols, S.A (GRFS) Spain $13.167B 15.08
Neurocrine Biosciences (NBIX) United States $10.211B 80.36
Jazz Pharmaceuticals (JAZZ) Ireland $9.238B 14.92
Ionis Pharmaceuticals (IONS) United States $8.578B 84.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.578B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.514B 0.00
United Therapeutics (UTHR) United States $7.433B 15.82
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.835B 395.56
Sage Therapeutics (SAGE) United States $5.036B 0.00
PTC Therapeutics (PTCT) United States $4.689B 0.00
ChemoCentryx (CCXI) United States $4.387B 0.00
Hypermarcas (HYPMY) Brazil $4.320B 15.86
Cronos Group (CRON) Canada $4.006B 0.00
FibroGen (FGEN) United States $3.919B 0.00
Pacira BioSciences (PCRX) United States $3.352B 72.79
Corcept Therapeutics (CORT) United States $3.209B 31.03
Nektar Therapeutics (NKTR) United States $3.193B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.891B 14.76
Xencor (XNCR) United States $2.841B 0.00
Revolution Medicines (RVMD) United States $2.657B 0.00
Tilray (TLRY) Canada $2.478B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.830B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.814B 15.52
Translate Bio (TBIO) United States $1.736B 0.00
Heron Therapeutics (HRTX) United States $1.666B 0.00
USANA Health Sciences (USNA) United States $1.665B 14.66
Endo (ENDP) Ireland $1.663B 2.52
Ocular Therapeutix (OCUL) United States $1.626B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.517B 0.00
Trillium Therapeutics (TRIL) Canada $1.511B 0.00
ImmunoGen (IMGN) United States $1.476B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.454B 10.10
Theravance Biopharma (TBPH) Cayman Islands $1.153B 0.00
Karyopharm Therapeutics (KPTI) United States $1.128B 0.00
Zogenix (ZGNX) United States $1.056B 0.00
Radius Health (RDUS) United States $1.049B 0.00
Indivior (INVVY) United States $1.046B 0.00
ORGANOGENESIS (ORGO) United States $1.023B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.971B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
VAXART, INC (VXRT) United States $0.804B 0.00
Collegium Pharmaceutical (COLL) United States $0.771B 45.49
Acutus Medical (AFIB) United States $0.760B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.746B 0.00
Esperion Therapeutics (ESPR) United States $0.746B 0.00
Chinook Therapeutics (KDNY) United States $0.665B 0.00
Aerie Pharmaceuticals (AERI) United States $0.661B 0.00
Flexion Therapeutics (FLXN) United States $0.646B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.644B 0.00
Ardelyx (ARDX) United States $0.625B 0.00
Siga Technologies (SIGA) United States $0.573B 16.09
Molecular Templates (MTEM) United States $0.554B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.553B 0.00
Harpoon Therapeutics (HARP) United States $0.542B 0.00
Sundial Growers (SNDL) Canada $0.488B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.487B 0.00
PROFOUND MEDICL (PROF) Canada $0.480B 0.00
Akebia Therapeutics (AKBA) United States $0.458B 0.00
Altimmune (ALT) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.437B 0.00
TherapeuticsMD (TXMD) United States $0.432B 0.00
DURECT (DRRX) United States $0.429B 0.00
CASI Pharmaceuticals (CASI) United States $0.413B 0.00
Rafael Holdings (RFL) United States $0.410B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.385B 0.00
Concert Pharmaceuticals (CNCE) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.366B 9.54
Matinas Biopharma Holdings (MTNB) United States $0.333B 0.00
Alpine Immune Sciences (ALPN) United States $0.331B 0.00
MEI Pharma (MEIP) United States $0.323B 0.00
Jounce Therapeutics (JNCE) United States $0.309B 0.00
KalVista Pharmaceuticals (KALV) United States $0.308B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 19.10
Lannett Co Inc (LCI) United States $0.286B 7.54
Xeris Pharmaceuticals (XERS) United States $0.281B 0.00
Menlo Therapeutics (VYNE) United States $0.277B 0.00
Redhill Biopharma (RDHL) Israel $0.276B 0.00
Otonomy (OTIC) United States $0.275B 0.00
Jaguar Animal Health (JAGX) United States $0.268B 0.00
Aclaris Therapeutics (ACRS) United States $0.262B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
CTI BioPharma (CTIC) United States $0.248B 0.00
IMV INC (IMV) Canada $0.231B 0.00
Oncternal Therapeutics (ONCT) United States $0.222B 0.00
OptiNose (OPTN) United States $0.221B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.209B 0.00
Infinity Pharmaceuticals (INFI) United States $0.189B 0.00
Aquestive Therapeutics (AQST) United States $0.186B 0.00
ProPhase Labs (PRPH) United States $0.186B 0.00
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.168B 0.00
IsoRay (ISR) United States $0.167B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.166B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.157B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Champions Oncology (CSBR) United States $0.150B 0.00
Onconova Therapeutics (ONTX) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Heat Biologics (HTBX) United States $0.142B 0.00
Novan (NOVN) United States $0.142B 0.00
MediWound (MDWD) Israel $0.137B 0.00
Lipocine (LPCN) United States $0.108B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.097B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.090B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.083B 160.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.078B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
AgeX Therapeutics (AGE) United States $0.073B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.073B 0.00
Biomerica (BMRA) United States $0.071B 0.00
Recro Pharma (REPH) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.059B 0.00
Vical (BBI) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.059B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 25.00
PolarityTE (PTE) United States $0.047B 0.00
Regulus Therapeutics (RGLS) United States $0.047B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.59
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
Flex Pharma (SLRX) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 32.31
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00